Digitization: the end-to-end solution for the decentralization of advanced therapies

Emmanuel Casasola, Annie Prescott, Joseph Higdon

29 July 2025

Register

Strategic human raw material selection for cell therapy manufacturing

Daniel Benitez-Ribas

16 July 2025

Register

Optimizing iPSC-derived cell therapy development

Omar Farah

09 July 2025

Register

To 1000L and beyond: streamlining AAV manufacturing with transfection complex stabilization

Leisha Kopp, Mason Bonitz

03 June 2025

Watch

Transforming viral vector manufacturing with next-generation CGMP plasmids platform

John Bowen, Brian Tomkowicz

02 April 2025

Watch

GMP or not? Understanding raw material quality grades and requirements for ATMP manufacturing

Lili Belcastro, Basak Clements, Claire Wartel

18 March 2025

Watch

Advancing AAV manufacturing: strategic insights and cost-effective solutions for the future of gene therapies

Michael DiBiasio-White, Ying Cai, Roland Pach

06 February 2025

Watch

Preserving the future of medicine: standardizing leukapheresis materials with cryopreservation for scalable cell therapies

R Luke, M Giedlin, D Clarke et al

12 December 2024

Watch

When does outsourcing autologous collection center qualification and the cell therapy supply chain make sense?

Amy Hines, Jeni Newman, Marcel van Houten

14 November 2024

Watch

Comparing activation methods to yield clinical-scale expansion of gamma delta T cells

Chengkang Zhang

24 September 2024

Watch

The benefits of single-use systems for enhanced process security

Eoin Dolan

04 September 2024

Watch

Understanding and leveraging cord blood bank capabilities and practices in cell therapy development

J Aho, A Conerty, S Shields et al

15 August 2024

Watch

Supporting efficacy and scaling with a next-generation T cell AOF formulation medium

Alan Gutowski, Joanna Kern

23 July 2024

Watch

Navigating cold chain complexity with innovative solutions

Susan Li

17 July 2024

Watch

Creating a closed-process, semi-automated workflow for human MSC expansion, harvest, and final fill

Julien Muzard, Donnie Beers

30 May 2024

Watch

Simplifying the transition from R&D to GMP-ready LNP production

Benjamin Knappett

16 May 2024

Watch

Accelerate the scale-up to clinical phase: optimizing stem cell culture performance and viral vector titers

Sara Bursomanno

24 April 2024

Watch

Optimizing access to high quality, standardized, and compliant leukopaks for the development and commercialization of allogeneic therapies

Makensie Becker

18 April 2024

Watch

The role of AI in predicting stem cell donor availability

A Madbouly, J Mcatee, B Shaffer et al

31 January 2024

Watch

iPSC-ing into the future of cell therapy: expansion in a hollow-fiber bioreactor

Nathan Frank, Molly Tregidgo

21 November 2023

Watch

Strategic raw material selection for cell therapy commercialization

Kasey Kime, Lili Belcastro, Kyle Hondorp

09 November 2023

Watch